NYSE - Nasdaq Real Time Price USD
Teleflex Incorporated (TFX)
122.08
+1.51
+(1.25%)
At close: May 7 at 4:00:02 PM EDT
122.81
+0.73
+(0.60%)
Pre-Market: 5:50:35 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,010,144
3,047,324
2,974,489
2,791,041
2,809,563
Cost of Revenue
1,334,160
1,344,645
1,327,558
1,259,954
1,259,961
Gross Profit
1,675,984
1,702,679
1,646,931
1,531,087
1,549,602
Operating Expense
1,135,928
1,156,943
1,084,218
1,017,567
990,926
Operating Income
540,056
545,736
562,713
513,520
558,676
Net Non Operating Interest Income Expense
-71,145
-75,535
-72,301
-53,352
-55,641
Other Income Expense
-258,680
-394,723
-56,400
-14,249
56,433
Pretax Income
210,231
75,478
434,012
445,919
559,468
Tax Provision
60,706
5,316
76,440
83,003
74,349
Net Income Common Stockholders
149,388
69,675
356,328
363,139
485,374
Diluted NI Available to Com Stockholders
149,388
69,675
356,328
363,139
485,374
Basic EPS
3.25
--
7.58
7.74
10.38
Diluted EPS
3.23
--
7.53
7.68
10.23
Basic Average Shares
46,515.50
--
46,981
46,898
46,774
Diluted Average Shares
46,727
--
47,304
47,309
47,427
Total Operating Income as Reported
281,376
151,013
506,313
499,725
628,095
Total Expenses
2,470,088
2,501,588
2,411,776
2,277,521
2,250,887
Net Income from Continuing & Discontinued Operation
149,388
69,675
356,328
363,139
485,374
Normalized Income
431,759.12
437,254.39
404,045.60
374,512.70
436,191.59
Interest Income
8,260
8,009
12,781
912
1,328
Interest Expense
79,405
83,544
85,082
54,264
56,969
Net Interest Income
-71,145
-75,535
-72,301
-53,352
-55,641
EBIT
289,636
159,022
519,094
500,183
616,437
EBITDA
565,524
433,623
761,212
730,773
853,799
Reconciled Cost of Revenue
1,334,160
1,344,645
1,327,558
1,259,954
1,259,961
Reconciled Depreciation
275,888
274,601
242,118
230,590
237,362
Net Income from Continuing Operation Net Minority Interest
149,525
70,162
357,572
362,916
485,119
Total Unusual Items Excluding Goodwill
-396,819
-394,723
-56,400
-14,249
56,433
Total Unusual Items
-396,819
-394,723
-56,400
-14,249
56,433
Normalized EBITDA
962,343
828,346
817,612
745,022
797,366
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-114,584.88
-27,630.61
-9,926.40
-2,652.30
7,505.59
12/31/2021 - 3/17/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COO The Cooper Companies, Inc.
81.25
+0.84%
WST West Pharmaceutical Services, Inc.
213.15
+3.79%
HOLX Hologic, Inc.
55.43
+4.37%
ICUI ICU Medical, Inc.
134.50
+0.13%
XRAY DENTSPLY SIRONA Inc.
13.68
+2.32%
MMSI Merit Medical Systems, Inc.
94.22
+1.45%
RGEN Repligen Corporation
126.88
-2.70%
BAX Baxter International Inc.
30.72
+2.64%
BDX Becton, Dickinson and Company
167.14
+1.20%
AVTR Avantor, Inc.
11.94
-0.33%